Erratum: Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression (Virchows Arch (2013) 462 (437-443) DOI: 10.1007/s00428-013-1390-8);Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression

Virchows Archiv

Volumn 462, Issue 4, 2013, Pages 437-443

  Montani, Matteo ^a   Herrmanns, Thomas ^b   Müntener, Michael ^b   Wild, Peter ^b   Sulser, Tullio ^b   Kristiansen, Glen ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Androgen receptor; FoxA; Immunohistochemistry; MRP4; Prostate cancer

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; FORKHEAD BOX A1; MULTIDRUG RESISTANCE PROTEIN 4; PROSTATE SPECIFIC ANTIGEN; PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 84876471862     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1429-x     Document Type: Erratum

References (24)

1. Deeley RG, Westlake C, Cole SP (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86(3):849-899. doi: 10.1152/physrev.00035.2005 (Pubitemid 44033384)
2. Borst P, de Wolf C, van de Wetering K (2007) Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 453(5):661-673. doi: 10.1007/s00424-006-0054-9 (Pubitemid 46192537)
3. Kruh GD, Belinsky MG, Gallo JM, Lee K (2007) Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice. Cancer Metastasis Rev 26(1):5-14. doi: 10.1007/s10555-007-9039-1 (Pubitemid 46452179)
4. Russel FG, Koenderink JB, Masereeuw R (2008) Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci 29(4):200-207. doi: 10.1016/j.tips.2008.01.006
5. Cai C, Omwancha J, Hsieh CL, Shemshedini L (2007) Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells. Prostate Cancer Prostatic Dis 10(1):39-45. doi: 10.1038/sj.pcan.4500912 (Pubitemid 46358909)
6. Ho LL, Kench JG, Handelsman DJ, Scheffer GL, Stricker PD, Grygiel JG, Sutherland RL, Henshall SM, Allen JD, Horvath LG (2008) Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. Prostate 68(13):1421-1429. doi: 10.1002/pros.20809
7. Chen C, Klaassen CD (2004) Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. Biochem Biophys Res Commun 317(1):46-53. doi: 10.1016/j.bbrc.2004.03.014S0006291X04004887 (Pubitemid 38401963)
8. Maher JM, Cheng X, Tanaka Y, Scheffer GL, Klaassen CD (2006) Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. Biochem Pharmacol 71(10):1470-1478. doi: 10.1016/j.bcp.2006.02. 005
9. Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, Kaestner KH (2008) Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat Med 14(8):828-836. doi: 10.1038/nm.1853
10. Le Lay J, Kaestner KH (2010) The Fox genes in the liver: from organogenesis to functional integration. Physiol Rev 90(1):1-22. doi: 10.1152/physrev.00018.2009
11. Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ (2003) The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol 17(8):1484-1507. doi: 10.1210/me.2003-0020 (Pubitemid 36930465)
12. Yu X, Gupta A, Wang Y, Suzuki K, Mirosevich J, Orgebin-Crist MC, Matusik RJ (2005) Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Ann N Y Acad Sci 1061:77-93. doi: 10.1196/annals.1336.009 (Pubitemid 43211588)
13. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V (2005) From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A 102(33):11651-11656. doi: 10.1073/pnas.0505575102 (Pubitemid 41170781)
14. Nakshatri H, Badve S (2009) FOXA1 in breast cancer. Expert Rev Mol Med 11:e8. doi: 10.1017/S1462399409001008
15. Kaestner KH, Knochel W, Martinez DE (2000) Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14(2):142-146 (Pubitemid 30070978)
16. Carlsson P, Mahlapuu M (2002) Forkhead transcription factors: key players in development and metabolism. Dev Biol 250(1):1-23
17. Gerhardt J, Montani M, Wild P, Beer M, Huber F, Hermanns T, Muntener M, Kristiansen G (2012) FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. Am J Pathol 180(2):848-861. doi: 10.1016/j.ajpath.2011.10.021
18. Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, Dahl E, Hinzmann B, Specht T, Pervan J, Stephan C, Loening S, Dietel M, Rosenthal A (2005) Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 205(3):359-376. doi: 10.1002/path.1676 (Pubitemid 40253926)
19. Tischler V, Fritzsche FR, Wild PJ, Stephan C, Seifert HH, Riener MO, Hermanns T, Mortezavi A, Gerhardt J, Schraml P, Jung K, Moch H, Soltermann A, Kristiansen G (2010) Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer 10:273. doi: 10.1186/1471-2407-10-273
20. Peng XX, Shi Z, Damaraju VL, Huang XC, Kruh GD, Wu HC, Zhou Y, Tiwari A, Fu L, Cass CE, Chen ZS (2008) Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine. Leuk Res 32(5):799-809. doi: 10.1016/j.leukres.2007.09.015 (Pubitemid 351323936)
21. Sekine S, Ogawa R, Ojima H, Kanai Y (2011) Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma. Cancer Sci 102(9):1742-1747. doi: 10.1111/j.1349-7006.2011.01990.x
22. Copsel S, Garcia C, Diez F, Vermeulem M, Baldi A, Bianciotti LG, Russel FG, Shayo C, Davio C (2011) Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem 286(9):6979-6988. doi: 10.1074/jbc.M110.166868
23. Mohler JL (2008) A role for the androgen-receptor in clinically localized and advanced prostate cancer. Best Pract Res Clin Endocrinol Metab 22(2):357-372. doi: 10.1016/j.beem.2008.01.009 (Pubitemid 351611955)
24. Gao N, Ishii K, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, Stoffel M, Hayward SW, Matusik RJ (2005) Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 132(15):3431-3443. doi: 10.1242/dev.01917 (Pubitemid 41246118)